Tech Company Financing Transactions
Teewinot Life Sciences Funding Round
On 5/2/2017, Teewinot Life Sciences raised $12.3 million in Series B funding from Tuatara Capital and private investors.
Transaction Overview
Company Name
Announced On
5/2/2017
Transaction Type
Venture Equity
Amount
$12,300,000
Round
Series B
Investors
Tuatara Capital (Lead Investor) (Marc Riiska)
Proceeds Purpose
The capital raised will be used for a variety of activities including enhancement and acceleration of research and development activities, expanding business development opportunities, and adding to the existing patent portfolio.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
12005 Whitmarsh Ln.
Tampa, FL 33626
USA
Tampa, FL 33626
USA
Phone
Website
Email Address
Overview
Teewinot Life Sciences Corporation is an international biopharmaceutical company focused on advanced pharmaceutical research and the use of novel biosynthetic processes such as biocatalysis and synthetic biology for cannabinoid manufacture.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Charles Brink
Chief Information Officer
Eric Walker
Chief Scientific Officer
Malcolm Kavarana
VP - Finance
Bryan Brink
Browse more venture capital transactions:
Prev: 5/2/2017: ReThink Medical venture capital transaction
Next: 5/2/2017: Airwallex venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We document every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs